APA (7th ed.) Citation

SW, S., N, B., & EA, H. (2021). Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply. JAMA, 326(11), 1069. https://doi.org/10.1001/jama.2021.11480

Chicago Style (17th ed.) Citation

SW, Syversen, Bolstad N, and Haavardsholm EA. "Therapeutic Drug Monitoring Vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply." JAMA 326, no. 11 (2021): 1069. https://doi.org/10.1001/jama.2021.11480.

MLA (9th ed.) Citation

SW, Syversen, et al. "Therapeutic Drug Monitoring Vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply." JAMA, vol. 326, no. 11, 2021, p. 1069, https://doi.org/10.1001/jama.2021.11480.